Search

everythinglearnresearchcommunity

for

Search:↓

Natural products in cosmetics are beneficial for skin and hair care with low toxicity.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

Tailored nonsurgical cosmetic procedures are crucial for safely treating diverse skin types, especially skin of color.

Improved dermabrasion techniques in 1987 led to better treatment results for skin issues like acne scars.

Nonablative radiofrequency treatments, especially microneedle and fractional types, can improve acne scars by 25%–75% after 3-4 sessions, with full results in 3 months and some side effects.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Women with PCOS are more likely to have skin problems like excessive hair, acne, and hair loss.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Research on the human skin microbiome has grown, focusing on skin health and diseases, with more studies needed on antibiotic resistance and AI applications.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Clausena anisata may be effective in treating acne due to its ability to fight bacteria, reduce inflammation, and possibly lower sebum production.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Wild strawberry waste extract can be a sustainable cosmetic ingredient for treating acne and hair loss.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.